MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    The Impact of Demographic Factors on Skull Density Ratios in a Hawaii Cohort

    K. Thai, F. Gao, M. Morita, R. Shuman, M. Faouzi, E. Krening, M. Bruno (Honolulu, USA)

    Objective: To understand the impact of demographic factors on skull density ratio (SDR) in Hawai‘i patients. Background: SDR is a validated indicator of the ability…
  • 2026 International Congress

    Association between Sleep Behaviors and Age at Onset of Parkinson’s Disease

    N. Zhou, M. Fang, L. He, T. Shao, Z. Liu, B. Liu, R. Li, W. Li (Beijing, China)

    Objective: To investigate the associations between multiple sleep behaviors and the age at onset (AAO) of Parkinson’s disease (PD) using the UK Biobank. Background: Sleep…
  • 2026 International Congress

    Do Digital Mobility Outcomes Differ Across Clinically Defined NSD-ISS Stages in Parkinson’s Disease?

    P. Tait, L. Alcock, C. Schlenstedt, C. Caroll, C. Becker, J. Buekers, B. Caulfield, A. Cereatti, S. Del-Din, L. Delgado-Ortiz, J. Garcia-Aymerich, S. Koch, P. Ginis, H. Gassner, A. Nieuwboer, J. Hausdorf, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall (Newcastle upon Tyne, United Kingdom)

    Objective: To determine whether digital mobility outcomes (DMOs) differ between individuals with relatively advanced PD grouped according to the clinical criteria of the Neuronal α-Synuclein…
  • 2026 International Congress

    Efficacy and Safety of Inhaled and Sublingual Apomorphine for On-Demand Treatment of OFF Episodes in Parkinson’s Disease: A Meta‑Analysis of Randomized Placebo‑Controlled Trials

    J. Martinez-Lemus, J. Rissardo, J. Patino, A. Caprara, A. Mcgarry, I. Walker (Houston, USA)

    Objective: To evaluate the efficacy and safety of inhaled (INH) and sublingual (SL) film apomorphine formulations for on-demand treatment of OFF episodes in Parkinson’s disease…
  • 2026 International Congress

    Skin Biopsy for Phosphorylated Alpha-Synuclein and DAT Imaging in Patients Diagnosed with Psychogenic Parkinsonism

    J. Phillips, V. Evidente, D. Evidente (Phoenix, USA)

    Objective: Objective:Describe the results of skin biopsy for phosphorylated alpha-synuclein (P-SYN) and dopamine transporter (DAT) imaging in patients previously diagnosed with psychogenic parkinsonism (PP) and…
  • 2026 International Congress

    Smell Testing in The Global Parkinson’s Genetics Program (GP2)

    S. Meyer, L. Jones, S. Waters, E. Navarro-Jones, M. Tan, K. Atterling-Brolin, L. Lange, M. Teresa Periñan, J. Trinh, C. Gabbert, A. Noyce, G. Genetics Program (London, United Kingdom)

    Objective: To identify cohorts with existing olfactory data within the Global Parkinson’s Genetics Program (GP2, http://gp2.org/). To support harmonisation across cohorts and facilitate future expansion…
  • 2026 International Congress

    Why Context Matters: The Influence of Medication and Environment on Real-World Gait in People with Parkinson’s Disease

    C. Lang, M. Galeon, C. Kirk, E. Packer, N. Ireson, V. Lanfranchi, L. Alcock, L. Rochester, A. Yarnall, S. Del Din*, D. Ravi* (Zurich, Switzerland)

    Objective: To quantify the extent to which contextual factors explain the variability in real-world gait outcomes in people with Parkinson’s disease (PwP) using machine learning…
  • 2026 International Congress

    High-Intensity Multimodal Training Through Group-Based Weighted Dance for Parkinson’s Disease: A Feasibility Study

    Y. Chen, S. Lai, C. Xu, K. Liu, L. Lo, T. Cheng, C. Li, C. Lui, Y. Wang, J. Jiang, Y. Wang, M. Huang (Kowloon, Hong Kong)

    Objective: To examine the feasibility and preliminary effects of a 4-week high-intensity multimodal training (HIMT) program [1], delivered through group-based weighted dance, for people with…
  • 2026 International Congress

    Real-World Clinical Outcomes of Adaptive versus Continuous Deep Brain Stimulation in Early-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis of 2024-2025 Trials

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To evaluate the comparative efficacy, safety, and energy efficiency of adaptive deep brain stimulation (aDBS) versus continuous deep brain stimulation (cDBS) in Parkinson’s disease…
  • 2026 International Congress

    Classification of Fallers in Parkinson’s Disease Through Machine Learning Based Feature Analysis

    SM. Kim, MK. Kim, MJ. Chung, JW. Cho, HJ. Yoo, JY. Youn (Seoul, Republic of Korea)

    Objective: To develop and validate a machine learning model integrating clinical and gait data to identify key clinical markers associated with faller status in Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 82
  • 83
  • 84
  • 85
  • 86
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley